🇺🇸 FDA
Patent

US 11518750

3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase

granted A61KA61K31/351A61K31/4192

Quick answer

US patent 11518750 (3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase) held by Northwestern University expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/351, A61K31/4192, A61K31/4427, A61K31/496